| Financial Year |
March 31 2023 |
| Monetary Funds |
2,224,419,131.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
458,670,348.35 |
| Accounts Receivable |
497,119,449.96 |
| Advances to Suppliers |
302,124,398.56 |
| Other Receivables |
24,071,067.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,069,555,600.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,391,196.32 |
| Total Current Assets |
5,991,674,698.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,022,260,553.19 |
| Investment Properties |
75,216,664.02 |
| Fixed Assetes |
4,897,377,813.33 |
| Under-construction Projects |
645,375,542.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
275,153,190.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
51,257,522.45 |
| Deferred Income Tax Assets |
47,768,399.09 |
| Other Non-Current Assets |
166,608,284.45 |
| Sub-Total of Non-Current Assets |
9,217,516,115.80 |
| Total Assets |
15,209,190,814.48 |
| Short-Term Loans |
602,073.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,394,035,353.96 |
| Accounts Payable |
767,677,476.25 |
| Accounts Received In Advance |
247,263.34 |
| Employee Compensation Payable |
36,708,353.93 |
| Taxes Payable |
36,595,269.86 |
| Interest Payable |
-- |
| Dividend Payable |
2,846,650.45 |
| Other payables |
161,426,844.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,109,413,064.90 |
| Other Current Liabilities |
196,534,557.63 |
| Sub-Total of Current Liabilities |
3,793,721,331.29 |
| Long-term Loans |
2,174,340,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,696,738.45 |
| Other Non-Current Liabilities |
1,571,315.93 |
| Sub-Total of Non-Current Liabilities |
2,457,716,896.33 |
| Total Liabilities |
6,251,438,227.62 |
| Paid-In Capital(Or Share Stock) |
1,350,024,855.00 |
| Capital Surplus |
3,883,188,829.01 |
| Surplus Reserve |
429,799,154.73 |
| LESS:Treasury Stock |
90,253,380.00 |
| Undistributed Profits |
3,271,687,155.80 |
| Minority Stockholder's Interest |
105,220,883.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,852,531,703.06 |
| Owner's Equity（Stockholder's Equity） |
8,957,752,586.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,209,190,814.48 |
